GB9811879D0 - Therapeutic agents - Google Patents
Therapeutic agentsInfo
- Publication number
- GB9811879D0 GB9811879D0 GBGB9811879.7A GB9811879A GB9811879D0 GB 9811879 D0 GB9811879 D0 GB 9811879D0 GB 9811879 A GB9811879 A GB 9811879A GB 9811879 D0 GB9811879 D0 GB 9811879D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- therapeutic agents
- therapeutic
- agents
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
- 239000003814 drug Substances 0.000 title 1
- 229940124597 therapeutic agent Drugs 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/453—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a six-membered ring with oxygen as a ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Diabetes (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Hematology (AREA)
- Endocrinology (AREA)
- Obesity (AREA)
- Hospice & Palliative Care (AREA)
- Psychology (AREA)
- Child & Adolescent Psychology (AREA)
- Emergency Medicine (AREA)
- Reproductive Health (AREA)
- Urology & Nephrology (AREA)
- Epidemiology (AREA)
- Addiction (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Priority Applications (21)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9811879.7A GB9811879D0 (en) | 1998-06-03 | 1998-06-03 | Therapeutic agents |
CA002333756A CA2333756A1 (en) | 1998-06-03 | 1999-05-26 | N-benzodioxanylmethyl-1-piperidyl-methylamine compounds having affinity for 5-ht receptors |
TR2000/03569T TR200003569T2 (tr) | 1998-06-03 | 1999-05-26 | 5-HT reseptörlerine karşı ilgileri olan N-benzodioksanilmetil-1-piperidil-metilamin bileşikleri. |
IDW20002519A ID27067A (id) | 1998-06-03 | 1999-05-26 | Bahan-bahan terapetik |
IL13955299A IL139552A0 (en) | 1998-06-03 | 1999-05-26 | N-benzodioxanylmethyl-1-piperidylmethylamine compounds having affinity for 5-ht receptors |
SK1760-2000A SK17602000A3 (sk) | 1998-06-03 | 1999-05-26 | N-benzodioxanylmetyl-1-piperidyl-metamínové zlúčeniny majúce afinitu k 5-ht receptorom |
BR9910927-1A BR9910927A (pt) | 1998-06-03 | 1999-05-26 | Composto, composições farmacêuticas, processo para tratamento de depressão, ansiedade, psicoses, doença de parkinson, obesidade, hipertensão, sìndrome de tourette, disfunção sexual, toxicomania, abuso de droga, distúrbios cognitivos, doença de alzheimer, demência senil, comportamento obsessivo-compulsivo, ataques de pânico, indisposições alimentares, anorexia, distúrbios cardiovascular e cerebrovascular, enxaqueca, diabetes melitus não dependente de insulina, hiperglicemia, constipação, arritmia, distúrbios do sistema neuroendócrino, tensão, hipertrofia prostática, sintomas extrapiramidais induzidos por drogas ou espasticidade, uso de um composto, e, processo para preparação do composto |
JP2000552113A JP2002517392A (ja) | 1998-06-03 | 1999-05-26 | 5htレセプターに対して親和性を有するn−ベンゾジオキサニルメチル−1−ピペリジル−メチルアミン化合物 |
CN99806908A CN1304408A (zh) | 1998-06-03 | 1999-05-26 | 对5-ht受体具有亲和力的n-苯并二噁烷基甲基-1-哌啶基-甲胺化合物 |
PL99344594A PL344594A1 (en) | 1998-06-03 | 1999-05-26 | N-benzodioxanylmethyl-1-piperidyl-methylamine compounds having affinity for 5-ht receptors |
EP99926434A EP1087964A1 (en) | 1998-06-03 | 1999-05-26 | N-benzodioxanylmethyl-1-piperidyl-methylamine compounds having affinity for 5-ht receptors |
KR1020007013670A KR20010052526A (ko) | 1998-06-03 | 1999-05-26 | 5-ht 수용체에 대해 친화성이 있는n-벤조디옥사닐메틸-1-피페리딜-메틸아민 화합물 |
AU43695/99A AU4369599A (en) | 1998-06-03 | 1999-05-26 | N-benzodioxanylmethyl-1-piperidyl-methylamine compounds having affinity for 5-HT receptors |
HU0102233A HUP0102233A2 (hu) | 1998-06-03 | 1999-05-26 | 5-HT-receptorokhoz affinitással rendelkező N-[(benzo-dioxanil)-metil]-N-[(4-piperidil)-metil]-amin-származékok, eljárás az előállításukra és ezeket tartalmazó gyógyszerkészítmények és alkalmazásuk |
PCT/EP1999/003648 WO1999062902A1 (en) | 1998-06-03 | 1999-05-26 | N-benzodioxanylmethyl-1-piperidyl-methylamine compounds having affinity for 5-ht receptors |
ARP990102619A AR018622A1 (es) | 1998-06-03 | 1999-06-03 | Compuestos (s)-(-)-1-[1-(4-sustituido o no sustituido, 2-metoxifenil)piperid-4-il]-n-(7-trifluorometil-2,3-dihidro-1,4-benzodioxin-2-il metil)metilamina,composiciones farmaceuticas que los comprenden, su uso para elaborar un medicamento y procedimiento para prepararlos |
CO99035020A CO5021190A1 (es) | 1998-06-03 | 1999-06-03 | Agentes terapeuticos |
ARP990102720 AR018636A1 (es) | 1998-06-03 | 1999-06-08 | Compuestos heterociclicos inhibidores de la fosfodiesterasa iv, composiciones farmaceuticas formuladas con dichos compuestos heterociclicos y uso de dichoscompuestos para la preparacion de dichas composiciones |
BG104988A BG104988A (bg) | 1998-06-03 | 2000-11-27 | N-бензодиоксанилметил-1-пиперидил-метиламин с афинитет към 5-нт рецептори |
NO20006041A NO20006041D0 (no) | 1998-06-03 | 2000-11-29 | N-Benzodioksanylmetyl-1-piperidyl-metylamin-forbindelser med affinitet for 5-HT-reseptorer |
HR20010005A HRP20010005A2 (en) | 1998-06-03 | 2001-01-02 | N-benzodioxanylmethyl-1-piperidyl-methylamine compounds having affinity for 5-ht receptors |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9811879.7A GB9811879D0 (en) | 1998-06-03 | 1998-06-03 | Therapeutic agents |
Publications (1)
Publication Number | Publication Date |
---|---|
GB9811879D0 true GB9811879D0 (en) | 1998-07-29 |
Family
ID=10833098
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GBGB9811879.7A Ceased GB9811879D0 (en) | 1998-06-03 | 1998-06-03 | Therapeutic agents |
Country Status (20)
Country | Link |
---|---|
EP (1) | EP1087964A1 (pt) |
JP (1) | JP2002517392A (pt) |
KR (1) | KR20010052526A (pt) |
CN (1) | CN1304408A (pt) |
AR (1) | AR018622A1 (pt) |
AU (1) | AU4369599A (pt) |
BG (1) | BG104988A (pt) |
BR (1) | BR9910927A (pt) |
CA (1) | CA2333756A1 (pt) |
CO (1) | CO5021190A1 (pt) |
GB (1) | GB9811879D0 (pt) |
HR (1) | HRP20010005A2 (pt) |
HU (1) | HUP0102233A2 (pt) |
ID (1) | ID27067A (pt) |
IL (1) | IL139552A0 (pt) |
NO (1) | NO20006041D0 (pt) |
PL (1) | PL344594A1 (pt) |
SK (1) | SK17602000A3 (pt) |
TR (1) | TR200003569T2 (pt) |
WO (1) | WO1999062902A1 (pt) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9915616D0 (en) * | 1999-07-05 | 1999-09-01 | Knoll Ag | Therapeutic agents |
GB0007376D0 (en) * | 2000-03-28 | 2000-05-17 | Knoll Ag | Therapeutic agents |
HUP0302016A2 (hu) * | 2000-05-12 | 2003-09-29 | Solvay Pharmaceuticals B.V. | Piperazin és piperidinvegyületek, ezeket tartalmazó gyógyászati készítmények, eljárás elżállításukra és alkalmazásuk |
JP2003532676A (ja) * | 2000-05-12 | 2003-11-05 | ソルベイ・フアーマシユーチカルズ・ベー・ブイ | CNS障害を治療するための組合せられたドーパミンD2、5−HT1Aおよびαアドレノレセプターアゴニスト作用、を有する化合物の使用 |
CA2597616A1 (en) | 2005-02-17 | 2006-08-24 | Wyeth | Cycloalkylfused indole, benzothiophene, benzofuran and indene derivatives |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2681325B1 (fr) * | 1991-09-16 | 1993-12-17 | Fabre Medicament Pierre | Derives de l'aminomethyl-4 piperidine, leur preparation et leur application en therapeutique. |
FR2701479B1 (fr) * | 1993-02-11 | 1995-05-12 | Pf Medicament | Nouveaux dérivés hétérocycliques de l'aminométhyl-4 pipéridine, leur préparation et leur application en thérapeutique. |
GB9318431D0 (en) * | 1993-09-06 | 1993-10-20 | Boots Co Plc | Therapeutic agents |
GB9514380D0 (en) * | 1995-07-13 | 1995-09-13 | Knoll Ag | Therapeutic agents |
-
1998
- 1998-06-03 GB GBGB9811879.7A patent/GB9811879D0/en not_active Ceased
-
1999
- 1999-05-26 CN CN99806908A patent/CN1304408A/zh active Pending
- 1999-05-26 TR TR2000/03569T patent/TR200003569T2/xx unknown
- 1999-05-26 JP JP2000552113A patent/JP2002517392A/ja active Pending
- 1999-05-26 KR KR1020007013670A patent/KR20010052526A/ko not_active Application Discontinuation
- 1999-05-26 CA CA002333756A patent/CA2333756A1/en not_active Abandoned
- 1999-05-26 IL IL13955299A patent/IL139552A0/xx unknown
- 1999-05-26 AU AU43695/99A patent/AU4369599A/en not_active Abandoned
- 1999-05-26 EP EP99926434A patent/EP1087964A1/en not_active Ceased
- 1999-05-26 SK SK1760-2000A patent/SK17602000A3/sk unknown
- 1999-05-26 WO PCT/EP1999/003648 patent/WO1999062902A1/en not_active Application Discontinuation
- 1999-05-26 ID IDW20002519A patent/ID27067A/id unknown
- 1999-05-26 PL PL99344594A patent/PL344594A1/xx not_active Application Discontinuation
- 1999-05-26 HU HU0102233A patent/HUP0102233A2/hu unknown
- 1999-05-26 BR BR9910927-1A patent/BR9910927A/pt not_active IP Right Cessation
- 1999-06-03 AR ARP990102619A patent/AR018622A1/es not_active Application Discontinuation
- 1999-06-03 CO CO99035020A patent/CO5021190A1/es unknown
-
2000
- 2000-11-27 BG BG104988A patent/BG104988A/bg unknown
- 2000-11-29 NO NO20006041A patent/NO20006041D0/no not_active Application Discontinuation
-
2001
- 2001-01-02 HR HR20010005A patent/HRP20010005A2/hr not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
KR20010052526A (ko) | 2001-06-25 |
WO1999062902A1 (en) | 1999-12-09 |
NO20006041L (no) | 2000-11-29 |
HRP20010005A2 (en) | 2001-12-31 |
BR9910927A (pt) | 2001-02-20 |
BG104988A (bg) | 2001-11-30 |
EP1087964A1 (en) | 2001-04-04 |
HUP0102233A2 (hu) | 2002-05-29 |
TR200003569T2 (tr) | 2001-04-20 |
ID27067A (id) | 2001-02-22 |
JP2002517392A (ja) | 2002-06-18 |
AR018622A1 (es) | 2001-11-28 |
SK17602000A3 (sk) | 2001-08-06 |
IL139552A0 (en) | 2002-02-10 |
CN1304408A (zh) | 2001-07-18 |
CO5021190A1 (es) | 2001-03-27 |
CA2333756A1 (en) | 1999-12-09 |
NO20006041D0 (no) | 2000-11-29 |
PL344594A1 (en) | 2001-11-05 |
AU4369599A (en) | 1999-12-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB9820113D0 (en) | Therapeutic agents | |
GB9816263D0 (en) | Therapeutic agents | |
GB9806102D0 (en) | Therapeutic agents | |
GB9804885D0 (en) | Therapeutic combination | |
GB9808663D0 (en) | Therapeutic agents | |
GB9801234D0 (en) | Therapeutic agents | |
GB9813576D0 (en) | Therapeutic agents | |
GB9813006D0 (en) | Therapeutic agents | |
GB9801210D0 (en) | Therapeutic agents | |
AP9901436A0 (en) | Therapeutic agents | |
GB9801397D0 (en) | Therapeutic agents | |
GB9801202D0 (en) | Therapeutic agents | |
GB9810092D0 (en) | Therapeutic agents | |
GB9811879D0 (en) | Therapeutic agents | |
GB9819484D0 (en) | Therapeutic agents | |
GB9815317D0 (en) | Therapeutic agents | |
GB9812662D0 (en) | Therapeutic use | |
GB9810920D0 (en) | Therapeutic use | |
GB9816897D0 (en) | Therapeutic use | |
GB9805716D0 (en) | Therapeutic agents | |
GB9817838D0 (en) | Therapeutic agents | |
GB9816723D0 (en) | Therapeutic agents | |
GB9811624D0 (en) | Therapeutic use | |
GB9821179D0 (en) | Therapeutic use | |
GB9812664D0 (en) | Therapeutic use |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AT | Applications terminated before publication under section 16(1) |